OPTION AGREEMENT AND PLAN OF MERGER BY AND AMONG ALCON RESEARCH, LTD., ITHACA MERGER SUB, INC., AND IVANTIS, INC. DATED AS OF November 9, 2018Option Agreement and Plan of Merger • February 15th, 2022 • Alcon Inc • Ophthalmic goods • Delaware
This OPTION AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of November 9, 2018 (the “Execution Date”), by and among (i) Alcon Research, Ltd., a Delaware corporation (the “Parent”), (ii) Ithaca Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Parent (the “Merger Sub”), (iii) Ivantis, Inc., a Delaware corporation (the “Company”), and (iv) following its nomination and appointment, and delivery by it of a joinder to this Agreement, in each case, in accordance with Section 10.1 of this Agreement, the Stockholder Representative (as defined herein).
AMENDMENT NO. 1 TO OPTION AGREEMENT AND PLAN OF MERGEROption Agreement and Plan of Merger • February 15th, 2022 • Alcon Inc • Ophthalmic goods
THIS AMENDMENT NO. 1 TO OPTION AGREEMENT AND PLAN OF MERGER (this “Amendment”) is made and entered into as of December 16, 2019 (the “Amendment Date”) by and among (a) Alcon Research, LLC, a Delaware limited liability company which was formerly known as Alcon Research, Ltd., a Delaware corporation (the “Parent”), (b) Ithaca Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Parent (the “Merger Sub”), (c) Ivantis, Inc., a Delaware corporation (the “Company”), and (d) the Stockholder Representative.
